Blaze Bioscience
Blaze Bioscience develops imaging agents and imaging systems that provide surgeons with real-time, intraoperative visualization of tumor tissue during cancer surgery. Its lead technology, Tumor Paint and the investigational agent tozuleristide (BLZ-100), enables near-infrared fluorescence imaging to help surgeons distinguish cancer from healthy tissue in procedures for breast, brain, skin, and head and neck cancers. The organization aims to improve surgical outcomes for cancer patients by making tumor visualization more sensitive, reliable, and accessible.
Facts
- HQ
- Seattle, WA 98109, USA
- Sectors
- Biotechnology, Medical imaging, Healthcare
- Founded
- 2011 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Blaze Bioscience Inc Seattle business license
- Members see funding amounts. .
- Founders
- James Olson
Is this your organization? Claim it
GeekWire Awards 2020 Goes Virtual; Ally Wins Startup of the Year as Bill Gates and Celebrities Celebrate
GeekWire held a virtual GeekWire Awards livestream honoring top Pacific Northwest tech companies and leaders across 12 categories, with winners accepting via Zoom and special video messages from figures like Bill Gates. Seattle startup Ally won Startup of the Year, and the event included entertainment such as The Drunken Tenorperforming an "Opera di Zoom."
Athira Pharma raises $85M Series B to push NDX-1017 toward FDA approval for Alzheimer’s, Parkinson’s and ALS
Seattle biotech Athira Pharma raised $85 million in a Series B round to advance NDX-1017, a regenerative therapy aimed at halting or reversing nerve damage in Alzheimer’s, Parkinson’s and ALS, with preliminary trial results reported as positive and potential market availability in 2–3 years.
U.S. VC Funding Falls 46% in April to $7.3B; Washington State Raises $190M in 21 Deals Led by Health and Biotech
U.S. venture capital investment plunged in April — down 46% from March to $7.3 billion and 43% year-over-year — while Washington state fared better with $190 million across 21 deals, helped by health and life-sciences financings.
People
-
Steven Daly Executive, Executive Officer, Director, President & Chief Executive Officer
Online
Questions about Blaze Bioscience
What is Blaze Bioscience?
blazebioscience.com
What is Blaze Bioscience known for?
Blaze Bioscience is known for Tumor Paint and the investigational agent tozuleristide (BLZ-100), which enable near-infrared fluorescence imaging to help distinguish cancer from healthy tissue in breast, brain, skin, and head and neck procedures.
Who are the people behind Blaze Bioscience?
Steven Daly is president and chief executive officer of Blaze Bioscience.
Where is Blaze Bioscience based?
Blaze Bioscience is based in Seattle, WA 98109, USA.
When was Blaze Bioscience founded?
Blaze Bioscience was founded in 2011.